Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benefits on Post-operative Pain of Intravenous Tranexamic Acid During Arthroscopic Shoulder Surgery
2024-518947-40-01Phase 3Completed
- Sponsor
- GBNA Polycliniques
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in postoperative pain, sponsored by GBNA Polycliniques. Primary endpoint: Use of morphine treatments in the 24 postoperative hours. Started Jan 2025; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2024-518947-40-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518947-40-01.